Dr. Jacqueline Lui, Managing Director and Dr. Ken Chow, Patent Scientist of Eagle IP Limited, joined the Seminar on Canadian Capabilities & Networking Luncheon and met with the Canadian Medical Devices Mission participants, organized by the Consulate General of Canada and the Hong Kong Trade Development Council, at the HK Convention & Exhibition Centre.
我們過去活動
Recommended Insights
Inventive Step for an Enantiomer over a Racemate: “L-ornidazole” Patent Invalidation Case
2023年11月27日Each year, China’s Supreme People’s Court (SPC) issues its annual “Judgment Digests”, which includes a list of “48 typical cases” highlighting representative SPC decisions in the previous year. The Judgment Digests help us understand more about the SPC’s judicial ideology, trial concepts, and adjudication methods in dealing with difficult and sophisticated legal issues as well […]
閱讀更多 >
China Joins Two WIPO Treaties, the Hague System and the Marrakesh Treaty
2022年2月11日It has been two challenging years, yet there are many reasons to still have hope. We wish you a blessed Lunar New Year as we welcome the year of the Tiger. We wanted to highlight a few new developments in China. China has joined the Hague System for the International Registration of Industrial Designs, submitting […]
閱讀更多 >
CNIPA Releases Interim Measures for the Amended Chinese Patent Law Going Into Effect June 1, 2021
2021年5月28日Breaking News! We finally have more details about the new Chinese Patent Law which will go into effect on June 1, 2021. The full set of measure can be found at this link. Below are some pertinent points. No Implementation Rules . . . . Yet The new Implementation Rules will not be available by […]
閱讀更多 >
China Hands Down First Batch of Patent Linkage “Paragraph IV” Litigation Results
2022年6月30日China has been implementing a plethora of new laws and measures that are particularly favorable to drug companies, such as patent term extension and patent linkage. Details of the new implementation measures for patent linkage (technically “early dispute resolution mechanisms for drug patents”) came into effect on July 4, 2021. At around the same time, […]
閱讀更多 >